Tag:
Nestle
Latest Headlines
Latest Headlines
Pfizer gets $11.85B in nutrition sale to Nestlé
As expected, Nestlé has prevailed in the steeplechase for Pfizer's nutrition unit.
Reuters: Danone bids $11 billion for Pfizer baby formula business
Danone is prepared to put up some serious cash to outbid Nestlé in the heated auction for Pfizer's baby formula business.
WSJ: Pfizer poised to sell nutrition biz to Nestlé for $9B-plus
Besides Nestlé, Pfizer had been entertaining offers from Danone and Mead Johnson Nutrition in auctioning off the unit.
Sources: Nestle leads in Pfizer unit bid, but don't count out Danone-Mead
It's Nestle ( $NSRGY ) versus the Danone-Mead Johnson team for Pfizer's ( $PFE ) $10 billion infant nutrition unit, and the Swiss company has an edge, according to sources cited by Reuters . But don't count out the Danone-Mead Johnson group just yet.
Field narrows in contest for Pfizer's nutrition unit
The contest for Pfizer's nutrition unit is heating up.
Pfizer reportedly weighing animal health IPO
Pfizer isn't saying much about its divestment plans. But that doesn't stop other people from talking. The latest? An IPO for the animal-health division, reported by the Financial Times . The...
Reuters: Nestle leads pack of bidders for Pfizer nutrition unit
Nestle is the front-runner for Pfizer's nutrition business, Reuters' sources say. The Swiss company is vying with France's Danone for the Pfizer ( $PFE ) unit, which the drugmaker marked for sale or
Valeant, J&J, Nestle nab new businesses
Here a deal, there a deal, everywhere a deal today: Three companies have struck sub-billion-dollar agreements, each with a different strategy in mind. Valeant Pharmaceuticals has agreed to buy
Nestlé sweetens chronic disease division with $1.4B Prometheus buyout
Anxious to build up a new healthcare division which promises to meld diagnostics, pharma and nutrition into a new profit center, Nestlé has acquired San Diego-based Prometheus Laboratories, a
